VEGFA and neoplasm: Allen et al. contemporarily observed that combination therapy using blocking antibodies against VEGFR2 and PD-L1 resulted in enhanced cytotoxic activity, together with an increased normalizing effect of VEGF blockade on tumor vasculature [119].